Cary Street Partner Investment Advisory »

Verve Therapeutics shares owned by Cary Street Partner Investment Advisory

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Cary Street Partner Investment Advisory from 13F filings

Historical chart of Cary Street Partner Investment Advisory investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Cary Street Partner Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Cary Street Partner Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-09-30 $13k 1.0k 13.26
2023-06-30 $19k 1.0k 18.75
2023-03-31 $19k 1.3k 14.42
2022-12-31 $25k 1.3k 19.35

More positions owned by Cary Street Partner Investment Advisory

Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Amazon Stock (AMZN)
Broadcom Stock (AVGO)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Meta Platforms Inc Cl A Stock (META)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Energy Transfer L P Com Ut Ltd Ptn Stock (ET)
Visa Inc Com Cl A Stock (V)
Mastercard Incorporated Cl A Stock (MA)
Targa Res Corp Stock (TRGP)

View all positions for Cary Street Partner Investment Advisory

Top funds holding Verve Therapeutics

XTX Topco
Greenland Capital Management
DekaBank Deutsche Girozentrale
Skopos Labs
Advisor Group Holdings

View all funds holding Verve Therapeutics